Effect of theaflavin-3,3′-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota
2022 · Frontiers in Pharmacology · 15 citations
https://doi.org/10.3389/fphar.2022.925264